JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on March 6, 2008; DOI: 10.1124/jpet.108.136895


0022-3565/08/3253-910-919$20.00
JPET 325:910-919, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
jpet.108.136895v1
325/3/910    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whiteaker, P.
Right arrow Articles by McIntosh, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whiteaker, P.
Right arrow Articles by McIntosh, J. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*(L)-HISTIDINE

CELLULAR AND MOLECULAR

Synthesis and Characterization of 125I-{alpha}-Conotoxin ArIB[V11L;V16A], a Selective {alpha}7 Nicotinic Acetylcholine Receptor AntagonistFormula

Paul Whiteaker, Michael J. Marks, Sean Christensen, Cheryl Dowell, Allan C. Collins, and J. Michael McIntosh

Division of Neurobiology, Barrow Neurological Institute, Phoenix, Arizona (P.W.); Institute for Behavioral Genetics, University of Colorado, Boulder, Colorado (M.J.M., A.C.C.); and Departments of Biology (S.C., C.D., J.M.M.) and Psychiatry (J.M.M.), University of Utah, Salt Lake City, Utah

The {alpha}7 nicotinic acetylcholine receptors (nAChRs) are widely expressed both in the central nervous system (CNS) and periphery. In the CNS, 125I-{alpha}-bungarotoxin is commonly used to identify {alpha}7 nAChRs specifically. However, {alpha}-bungarotoxin also interacts potently with {alpha}1* and {alpha}9{alpha}10 nAChRs, two receptor subtypes in peripheral tissues that are colocalized with the {alpha}7 subtype. [3H]Methyllycaconitine is also frequently used as an {alpha}7-selective antagonist, but it has significant affinity for {alpha}6* and {alpha}9{alpha}10 nAChR subtypes. In this study, we have developed a highly {alpha}7-selective {alpha}-conotoxin radioligand by iodination of a naturally occurring histidine. Both mono- and diiodo derivatives were generated and purified (specific activities were 2200 and 4400 Ci mmol-1, respectively). The properties of the mono- and diiodo derivatives were very similar to each other, but the diiodo was less stable. For monoidodo peptide, saturation binding to mouse hippocampal membranes demonstrated a Kd value of 1.15 ± 0.13 nM, similar to that of 125I-{alpha}-bungarotoxin in the same preparations (0.52 ± 0.16 nM). Association and dissociation kinetics were relatively rapid (kobs for association at 1 nM was 0.027 ± 0.007 min-1; koff = 0.020 ± 0.001 min-1). Selectivity was confirmed with autoradiography using {alpha}7-null mutant tissue: specific binding was abolished in all regions of {alpha}7-/- brains, whereas wild-type mice expressed high levels of labeling and low nonspecific binding. 125I-{alpha}-conotoxin ArIB[V11L; V16A] should prove useful where {alpha}7 nAChRs are coexpressed with other subtypes that are also labeled by existing ligands. Furthermore, true equilibrium binding experiments could be performed on {alpha}7 nAChRs, something that is impossible with 125I-{alpha}-bungarotoxin.


Received January 19, 2008; accepted March 4, 2008.

Address correspondence to: Dr. J. Michael McIntosh, University of Utah, 257 S. 1400 East, Salt Lake City, UT 84112. E-mail: mcintosh.mike{at}gmail.com







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.